Helicobacter pylori in children

Helicobacter. 2016 Sep:21 Suppl 1:49-54. doi: 10.1111/hel.12341.

Abstract

Helicobacter pylori infection in early childhood may differ in many aspects compared to infection in adulthood: the immune response in the gut, the type and prevalence of complications within and outside the stomach, and the impact on long-term health. In high prevalence countries, transient infections seem to be common in infants and toddlers, and the consequences of this phenomenon on the short- and long-term immune response are still unclear. Other controversial issues are related to the question of which H. pylori-infected children benefit from treatment and which is the best regimen to eradicate the infection in the presence of a worldwide increasing antibiotic resistance. The first large-scale randomized placebo-controlled vaccination trial in schoolchildren indicates that prevention of the infection may be possible.

Keywords: diagnosis; epidemiology; pathophysiology; treatment.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Controlled Clinical Trials as Topic
  • Drug Resistance, Bacterial
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / epidemiology*
  • Helicobacter Infections / prevention & control
  • Humans
  • Infant
  • Treatment Outcome
  • Vaccination / methods

Substances

  • Anti-Bacterial Agents